34
Views
11
CrossRef citations to date
0
Altmetric
Review

Prostate-sparing cystectomy: has Pandora’s box been opened?

, , , &
Pages 1003-1014 | Published online: 10 Jan 2014

References

  • Jemal A, Siegel R, Ward E et al. Cancer statistics 2006. CA Cancer J. Clin.56, 106–130 (2006).
  • Dinney CP. Therapy of invasive bladder cancer. Urology67, 56–59 (2006).
  • Stein JP, Skinner DG. Radical cystectomy for invasive bladder cancer: long-term results of a standard procedure. World J. Urol.24, 296–304 (2006).
  • Parekh DJ, Bochner BH, Dalbagni G. Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments. J. Clin. Oncol.35, 5519–5527 (2006).
  • Hautmann RE, Gschwend JE, de Petriconi RC, Kron MK, Volkmer B. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery-only series in the neobladder era. J. Urol.176, 486–492 (2006).
  • Madersbacher S, Hochreiter W, Burkhard F et al. Radical cystectomy for bladder cancer today – a homogenous series without neoadjuvant therapy. J. Clin. Oncol.21, 690–686 (2003).
  • Montie JE. Against bladder sparing surgery. J. Urol.162, 452–455 (1999).
  • Herr HW, Sogani PC. Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? J. Urol.166, 1296–1299 (2001).
  • Stein JP. Indications for early cystectomy. Urology62, 591–595 (2003).
  • Boyd SD, Feinberg SM, Skinner DG, Lieskovsky G, Baron D, Richardson J. Quality of life survey of urinary diversion patients: comparison of ileal conduits versus continent Kock ileal reservoirs. J. Urol.138, 1386–1389 (1987).
  • Nordstrom GM, Nyman CR. Male and female sexual function and activity following ileal conduit urinary diversion. Br. J. Urol.70, 33–39 (1992).
  • Schover LR, Evans R, von Eschembach AC. Sexual rehabilitation and male radical cystectomy. J. Urol.136, 1015–1017 (1986).
  • Hart S, Skinner EC, Meyerowitz BE, Boyd S, Lieskovsky G, Skinner DG. Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, or cutaneous or urethral Kock pouch. J. Urol.162, 77–81 (1999).
  • Zippe CD, Raina R, Massanyi EZ et al. Sexual function after male radical cystectomy in a sexually active population. Urology64, 682–685 (2004).
  • Hautmann RE, De Petriconi R, Gottfried H-W, Kleinschmidt K, Mattes R, Paiss T. The ileal neobladder. Complications and functional results in 363 patients after 11 years of follow-up. J. Urol.161, 422–428 (1999).
  • Maderbascher S, Möhrle K, Burkhard F, Studer UE. Long-term voiding pattern of patients with ileal orthotopic bladder substitutes. J. Urol.197, 2052–2057 (2002).
  • Henningsohn L, Wijkström H, Pedersen J et al. Time after surgery, symptoms and well-being in survivors of urinary bladder cancer. BJU Int.91, 325–330 (2003).
  • Lebret T, Hervé JM, Yonneau L et al. Study of survival after cystectomy for bladder cancer. Report of 504 cases. Prog. Urol.10, 551–60 (2000).
  • Schlegel PN, Walsh PC. Neuroanatomical approach to radical cystectomy with preservation of sexual function. J. Urol.138, 1402–1406 (1987).
  • Rossetti SR, Terrone C, Ceratti G, Favro M. Supra-ampullar cystoprostatectomy: indications and technique. Eur. Urol.30, 266–267 (1996).
  • Schilling A. Transprostatic selective cystectomy with an ileal bladder. Eur. Urol.18, 253–257 (1990).
  • Spitz A, Stein JP, Lieskovsky G, Skinner DG. Orthotopic urinary diversion with preservation of erectile and ejaculatory function in men requiring radical cystectomy for nonurothelial malignancy: a new technique. J. Urol.161, 1761–1764 (1999).
  • Horenblas S, Meinhardt W, Ijzerman W, Moonen LF. Sexuality preserving cystectomy and neobladder: initial results. J. Urol.166, 837–840 (2001).
  • Colombo R, Bertini R, Salonia A et al. Nerve and seminal sparing radical cystectomy with orthotopic urinary diversion for select patients with superficial bladder cancer: an innovative surgical approach. J. Urol.165, 51–55 (2001).
  • Vallancien G, Abou EF, Cathelineau X, Baumert H, Fromont G, Guillonneau B. Cystectomy with prostate sparing for bladder cancer in 100 patients: 10-year experience. J. Urol.168, 2413–2417 (2002).
  • Meinhardt W, Horenblas S. Sexuality preserving cystectomy and neobladder (SPCN): functional results of a neobladder anastomosed to the prostate. Eur. Urol.43, 646–650 (2003).
  • Colombo R, Bertini R, Salonia A et al. Overall clinical outcomes after nerve and seminal sparing radical cystectomy for the treatment of organ confined bladder cancer. J. Urol.171, 1819–1822 (2004).
  • Terrone C, Cracco C, Scarpa RM, Scarpa RM, Rossetti SR. Supraampullar cystectomy with preservation of sexual function and ileal orthotopic reservoir for bladder tumor: twenty years of experience. Eur. Urol.46, 264–270 (2004).
  • Muto G, Bardari F, D’Urso L, Giona C. Seminal sparing cystectomy and ileocapsuloplasty: long-term follow-up results. J. Urol.172, 76–80 (2004).
  • Botto H, Sebe P, Molinie V, Herve JM, Yonneau L, Lebret T. Prostatic capsule and seminal-sparing cystectomy for bladder carcinoma: initial results for selected patients. BJU Int.94, 1021–1025 (2004).
  • Martis GD, Elia G, Diana M, Ombres M, Mastrangeli B. Prostatic capsule- and nerve-sparing cystectomy in organ confined bladder cancer: preliminary results. World J. Surg.29, 1277–1281 (2005).
  • Nieuwenhuijzen JA, Meinhardt W, Horenblas S. Clinical outcomes after sexuality preserving cystectomy and neobladder (prostate sparing cystectomy) in 44 patients. J. Urol.173, 1314–1317 (2005).
  • Arroyo C, Andrews H, Rozet F, Cathelineu X, Vallencien G. Laparoscopic prostate-sparing radical cystectomy: the Montsouris technique and preliminary results. J. Endourol.19, 424–428 (2005).
  • Wunderlich H, Wolf M, Reichelt O, Frober R, Schubert J. Radical cystectomy with ultrasound-guided partial prostatectomy for bladder cancer: a complication-preventing concept. Urology68, 554–559 (2006).
  • Abuzeid AM, Saleem MD, Badawy AA, Abdelhafez AA. Genital sparing radical cystectomy for organ confined bladder carcinoma. Impact on tumor control and quality of life. J. Urol.173(Suppl. 4), 79 (2005).
  • Min Y, Wei-ming W, Ying-jian Z. Clinical outcomes of nerve and seminal sparing cystectomy for the treatment of malignant and nonmalignant bladder disease. J. Urol.173A, 05-AB-4392-AUA (2005).
  • Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA, Shappell SB. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J. Urol.171, 646–649 (2004).
  • Wood DP Jr, Montie JE, Pontes JE, Levin HS. Incidence of TCC in the prostate of radical cystectomy specimens: a prospective study. J. Urol.142, 83–85 (1989).
  • Reese JH, Freiha FS, Gelb AB et al. Transitional cell carcinoma of the prostate in patients undergoing radical cystoprostatectomy. J. Urol.147, 92–95 (1992).
  • Pettus JA, Al-Ahmadie H, Barocas DA et al. Prostate involvement by urothelial and prostatic carcinomas in radical cystoprostatectomy specimens J. Urol.175(Suppl. 4) 397 (2006).
  • Shen SS, Lerner SP, Muezzinoglu B, Truong LD, Amiel G, Wheeler TM. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Hum. Pathol.37, 726–734 (2006).
  • Donat SM, Wei DC, McGuire MS, Herr HW. The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer. J. Urol.165, 1580–1584 (2001).
  • Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J. Clin. Oncol.19, 666–675 (2001).
  • Ghoneim MA, El-Mekresh MM, El-Baz MA et al. Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1,026 cases. J. Urol.158, 393–399 (1997).
  • Kabalin JN, McNeal JE, Price HM, Freiha FS, Stamey TA. Unsuspected adenocarcinoma of the prostate in patients undergoing cystoprostatectomy for other causes: incidence, histology and morphometric observations. J. Urol.141, 1091–1094 (1989).
  • Montie JE, Wood DP Jr, Pontes JE, Boyett JM, Levin HS. Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer63, 381–385 (1989).
  • Wiezer AZ, Shah RB, Gilbert SB et al. Presence, location and significance of prostate cancer in patients undergoing radical cystoprostatectomy: feasibility of prostate-capsule sparing cystectomy. J. Urol.175(Suppl. 4), 397 (2006).
  • Hassan JM, Cookson MS, Smith JA, Chang SS. Patterns of initial transitional cell recurrence in patients after cystectomy. J. Urol.175, 2054–2057 (2006).
  • Greven KM, Spera JA, Solin LJ et al. Local recurrence after cystectomy alone for bladder carcinoma. Cancer69, 2767–2770 (1992).
  • Visser D, Niewenhuijzen JA, Horenblas J. Local recurrence after cystectomy and survival of patients with bladder cancer: a population based study in greater Amsterdam. J. Urol.174, 97–102 (2005).
  • Karakiewicz PI, Shahrokh FS, Ganesh SP et al. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. J. Urol.176, 1354–1362 (2006).
  • Hautmann RE, Stein JP. Neobladder with prostatic capsule and seminal-sparing cystectomy for bladder cancer: a step in the wrong direction. Urol. Clin. N. Am.32, 177–185, (2005).
  • Mansson A, Davidson A, Hunt S, Mansson W. The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a difference? BJU Int.90, 386–390 (2002).
  • Steers WD. Orthotopic neobladder: functional outcomes. World J. Urol.18, 330–337 (2000).
  • Ficarra V, Dalpiaz O, Alrabi N, Novara G, Galfano A, Artibani W. Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma. BJU Int.95, 786–790 (2005).
  • Pagano F, Bassi P, Galetti TP et al. Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. J. Urol.145, 45–50 (1991).
  • Herr HW, Bochner BH, Dalbagni G, Donat MS, Reuter VE, Bajorin DF. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J. Urol.167, 1295–1298 (2002).
  • Leissner J, Hohenfellner R, Thuroff JW, Wolf HK. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder: significance for staging and prognosis. BJU Int.85, 817–823 (2000).
  • Leissner J, Ghoneim MA, Abol-Enein H et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study. J. Urol.171, 139–144 (2004).
  • Amling CL, Trasher JB, Frazier HA et al. Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. J. Urol.151, 31–35 (1994).
  • Freeman JA, Esrig D, Stein JP et al. Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction. Cancer76, 833–839 (1995).
  • Soloway MS, Lopez AE, Patel J et al. Results of radical cystectomy for transitional cell carcinoma of the bladder and the effect of chemotherapy. Cancer73, 1926–1931 (1994).
  • Lee CT, Madii R, Daignault S et al. Cystectomy delay more than 3 months from initial bladder cancer diagnosis results in decreased disease specific and overall survival. J. Urol.175, 1262–1267 (2006).
  • Cookson MS, Herr HW, Zhang ZF. The treated natural history of high risk superficial bladder cancer: 15-year outcome. J. Urol.158, 62–67 (1997).
  • O’Donnell MA. Use of intravesical BCG in treatment of superficial bladder cancer. In: Bladder Cancer: Current Diagnosis and Treatment. Droller MJ (Ed.). Humana Press, NJ, USA 225–266 (2001).
  • Terrone C, Porpiglia F, Cracco C et al. Supra-ampullar cystectomy and ileal neobladder. Eur. Urol.50, 1223–1233 (2006).
  • Guazzoni G, Cestari A, Colombo R et al. Laparoscopic nerve- and seminal-sparing cystectomy with orthotopic ileal neobladder: the first three cases. Eur. Urol.44, 567–572 (2003).
  • Nixon RG, Chang SS, Lafleur BJ, Smith JA, Cookson MS. Carcinoma in situ and tumor multifocality predict the risk of prostatic urethral involvement at radical cystectomy in men with transitional cell carcinoma of the bladder. J. Urol.167, 502–505 (2002).
  • Kefer JC, Voelzke BB, Flanigan RC, Wojcik EM, Waters WB, Campbell SC. Risk assessment for occult malignancy in the prostate before radical cystectomy. Urology66, 1251–1255 (2005).
  • Kefer JC, Liu L, Klein EA, Campbell SC. Predicting occult malignancy in the prostate prior to radical cystectomy. J. Urol.177(Suppl. 4), 362 (2007).
  • Tal R, Baniel J. Sexual function-preserving cystectomy. Urology66, 235–241 (2005).
  • Sebe P, Traxer O, Cussenot O, Haab F, Thibault P, Gattegno B. Cystectomy with preservation of the prostate in the treatment of bladder tumors; anatomical basis, surgical techniques, indications and results. Prog. Urol.13, 1279–1285 (2003).
  • Miranda-Sousa AJ, Davila HH, Lockhart JL, Ordorica RC, Carrion RE. Sexual function after surgery for prostate or bladder cancer. Cancer Control13, 179–187 (2006).
  • Henningsohn L, Wijkstrom H, Dickman PW, Bergmark K, Steineck G. Distressful symptoms after radical cystectomy with urinary diversion for urinary bladder cancer: a Swedish population based study. Eur. Urol.40, 151–162 (2001).
  • Herr HW, Faulkner JR, Grossman HB et al. Surgical factors influence bladder cancer outcomes: a cooperative group report J. Clin. Oncol.22, 2781–2789 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.